Norman Sharpe

13.0k citations
113 papers · 9.8k indexed · 3 hit papers · h-index 38
Topics
Cardiovascular Function and Risk Factors (44 papers)Heart Failure Treatment and Management (40 papers)Blood Pressure and Hypertension Studies (16 papers)

In The Last Decade

Norman Sharpe

108 papers receiving 9.4k citations

Hit Papers

Cardiac remodeling—concepts and clinical implications: a ...199620262006201620002000199650010001.5k

Peers

Norman Sharpe
Comparison fields: 5 of 158
  • Cardiology and Cardiovascular Medicine 7.4k
  • Surgery 2.0k
  • Molecular Biology 1.3k
  • Radiology, Nuclear Medicine and Imaging 1.2k
  • Endocrinology, Diabetes and Metabolism 858
Replace Chu‐Pak Lau with:
Chu‐Pak Lau Hong Kong
Kurt Boman Sweden
Anita Deswal United States
Eric Leip United States
Graham S. Hillis Australia
Michaël Domanski United States
Cheuk‐Man Yu Hong Kong
Iain Squire United Kingdom
Joseph Hung Australia
Stefan Störk Germany
Norman Sharpe relative to Chu‐Pak Lau Hong Kong Chu‐Pak Lau's profile →
Citations per field
00.5×1.5×
Chu‐Pak Lau · 1×
Citations per year

Countries citing papers authored by Norman Sharpe

Since Specialization
Citations

This map shows the geographic impact of Norman Sharpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman Sharpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman Sharpe more than expected).

Fields of papers citing papers by Norman Sharpe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman Sharpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman Sharpe. The network helps show where Norman Sharpe may publish in the future.

Co-authorship network of co-authors of Norman Sharpe

This figure shows the co-authorship network connecting the top 25 collaborators of Norman Sharpe. A scholar is included among the top collaborators of Norman Sharpe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman Sharpe. Norman Sharpe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Effect of carvedilol in patients with or without renal impairment after myocardial infarction: analysis of the carvedilol post-infarct survival control in left ventricular dysfunction (CAPRICORN) study.
2
2
Cardiovascular Risk: A Paradigm Shift and New Global Challenge for Health Professionals
3
3 8
4 20
5 14
6 79
7 119
8 181
9 6
10 34
11
Pravastatin reduces the high rate of atherothrombotic complications in coronary heart disease patients with intermittent claudication
1
12 176
13
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodelingbreakdown →
1916
14 267
15 339
16
Management of acute myocardial infarction in Auckland.
9
17
Medical management after myocardial infarction: an evidence-based perspective.
1
18
Hospital admissions and deaths due to congestive heart failure in New Zealand, 1988-91.
61
19
Lowering Cholesterol Levels in Patients with Coronary Heart-Disease - the 4s Trial Showed That Lowering High Cholesterol Levels Improves Survival in Patients with Coronary Heart-Disease - Do the Benefits Extend to Those with Average Cholesterol Levels
2
20 38

About Norman Sharpe

Norman Sharpe is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine and Medical Laboratory Technology, having authored 113 papers that have together received 9.8k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (44 papers), Heart Failure Treatment and Management (40 papers) and Blood Pressure and Hypertension Studies (16 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (7.4k citations), Family Practice (121 citations) and Endocrinology, Diabetes and Metabolism (858 citations). Norman Sharpe has collaborated with scholars based in New Zealand, United States and Australia. Frequent co-authors include Martin G. St. John Sutton, Roberto Ferrari, Jay N. Cohn, Robert N. Doughty, Stephen MacMahon, Greg Gamble, Gillian Whalley, Judy Murphy, John Weinman and Keith J. Petrie. Their work appears in journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026